metastatic-recurrent HNSCC (mHNSCC) | |
mHNSCC - L2 - all population | |
durvalumab plus tremelimumab | EAGLE ... |
Study type:
delta: difference in rate or median (if available)
- About us - Contact us - Method - RSS Made with in Lyon - Credits - Privacy policy -